Genomind

Hospitals and Health Care • King of Prussia, Pennsylvania, United States • 51-100 Employees

Company overview

Headquarters	2200 Renaissance Blvd, King of Prussia, Pennsylvania 19406, US
Phone number	+18778958658
Website	genomind.com
NAICS	62
SIC	807
Keywords	Personalized Medicine, Healthcare Solutions, Health And Wellness, Telemedicine, Genetic Testing, Population Health, Medication Management, Precision Medicine, Pharmacogenetics, Risk Stratification, Scientific Education, Clinical Expertise, Consumer Genetics, Precision Health, Clinical Guidance, Treatment Optimization, Phd And Pharmd Consults, Prescription Genetic Testing, Prescription Guidance, Precision Healthcare
Employees	51-100
Socials

Key Contacts at Genomind

Bill Brown

Ceo

Ebru Sayan

Regional Director Of Sales And Marketing

Howard Niskar

National Sales Director

Thomas Mahoney

Senior Director Of Finance

Rob Dublin

Head Of Sales And Reimbursement

Russell Amato

Director Medical Affairs

John J. Rushton

Laboratory Director

Jay Lombard

Co Founder

Michael Wasielewski

East Area Director

Sheila Dickens

Director, Business Insights

Genomind Email Formats

Genomind uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@genomind.com), used 51.4% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@genomind.com	51.4%
{first initial}{last name}	jdoe@genomind.com	22.9%
{last name}{last name}	doedoe@genomind.com	22.9%
{first initial}.{last name}	j.doe@genomind.com	2.9%

About Genomind

Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care. Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only. Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order. If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. Learn more at www.genomind.com.

Genomind revenue & valuation

Annual revenue	$28,500,000
Revenue per employee	$432,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$91,200,000
Total funding	$20,600,000